Article
Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.
Infection - 1 Jun 2017
Suárez Isabelle, Roderus Lisa, van Gumpel Edeltraud, Jung Norma, Lehmann Clara, Fätkenheuer Gerd, Hartmann Pia, Plum Georg, Rybniker Jan
Abstract excerpt
BACKGROUND: Pneumocystis pneumonia (PCP) is an opportunistic and potentially life-threatening infection of immunocompromised individuals. A combination of trimethoprim-sulfamethoxazole is widely used for prophylaxis and treatment of PCP. Polymorphisms in the drug targets, the dihydropteroate synthase (DHPS) or the dihydrofolate reductase (DHFR) are presumably a reason for treatment failure. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
